Molecular Pharmaceutics

Diseases, Conditions, Syndromes

NIST clarifies structure of prospective vaccine for respiratory virus

No approved vaccine exists for RSV, a life-threatening virus that attacks the respiratory system. State-of-the-art neutron and X-ray scattering performed at the National Institute of Standards and Technology (NIST) may bring ...

Oncology & Cancer

New strategy for treating the most aggressive type of brain cancer

Researchers from the University of São Paulo (USP) in Brazil have developed a strategy for treating the most aggressive type of brain cancer in adults that combines a photoactive molecule and a chemotherapeutic agent—both ...

Neuroscience

Cannabidiol could help deliver medications to the brain

Cannabidiol (CBD), a non-psychoactive compound in cannabis, is being touted as beneficial for many health conditions, ranging from anxiety to epilepsy. Although much more research is needed to verify these claims, scientists ...

Medications

Heroin vaccine blocks lethal overdose

Scientists at The Scripps Research Institute (TSRI) have achieved a major milestone toward designing a safe and effective vaccine to both treat heroin addiction and block lethal overdose of the drug. Their research, published ...

Alzheimer's disease & dementia

Investigation into new molecules for potential Alzheimer's treatment

Two significant research studies have been published in Molecular Pharmaceutics and Current Alzheimer Research regarding molecules that could potentially treat Alzheimer's disease. The chief researcher in both studies was ...

Medical research

Intestinal flora effects drug response

Intestinal flora has multiple influences on human health, but researchers have revealed that it is also likely to have an effect on the body's response to drugs. Recent research from Kumamoto University in Japan strongly ...

page 2 from 4